Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Klodell

Thoracic Surgery (Cardiothoracic Vascular Surgery) Gainesville, FL Medical Doctor

NPI 1053347468 CMS profile 93033

6440 W Newberry Rd, Suite 102, Gainesville, FL 32605

Open in the dashboard

General payments

$102,284

262 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$717,902 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Charles Klodell of Gainesville, FL is reported in the CMS Open Payments database as having received $102,284 across 262 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $717,902 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,571 36
2024 General $7,580 29
2023 General $13,685 36
2022 General $35,551 47
2021 General $6,508 21
2020 General $22,999 41
2019 General $7,391 52

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Klodell
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Charles Klodell were reported at $8,571. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Charles Klodell Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $7,391 $886 $178–$3,167 $163
2020 $22,999 $341 $108–$1,605 $114
2021 $6,508 $453 $125–$1,886 $132
2022 $35,551 $695 $180–$2,566 $149
2023 $13,685 $745 $205–$2,662 $160
2024 $7,580 $799 $214–$2,967 $164
2025 $8,571 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $41,968 60 payments
  2. Edwards Lifesciences Corporation $29,803 92 payments
  3. Medtronic Vascular, Inc. $24,351 39 payments
  4. Abbott Laboratories $3,289 43 payments
  5. Boston Scientific Corporation $1,486 8 payments
  6. Abiomed $890 9 payments
  7. Regeneron Healthcare Solutions, Inc. $108 1 payment
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $97 1 payment
  9. Veran Medical Technologies, Inc. $82 1 payment
  10. Zimmer Biomet Holdings, Inc. $67 2 payments
  11. Other $143 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $53,706 17 payments
  2. Consulting Fee $19,875 5 payments
  3. Travel and Lodging $16,958 56 payments
  4. Food and Beverage $10,244 183 payments
  5. Honoraria $1,500 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $34,183 37 payments
  2. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $24,406 28 payments
  3. CoreValve Evolut Transcatheter Valve Systems $21,103 26 payments
  4. CoreValve Evolut Transcatheter Valve Systems $5,124 5 payments
  5. Edwards SAPIEN 3 Transcatheter Heart Valve $1,881 7 payments
  6. SAPIEN 3 Ultra RESILIA $1,720 23 payments
  7. ENDURANT IIS $1,684 11 payments
  8. Mitra Clip system $1,516 20 payments
  9. General Therapies $1,227 5 payments
  10. Impella $890 9 payments
  11. Other $2,808 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

70

Median for Thoracic Surgery: 42

Drug cost

$22,786

Median for Thoracic Surgery: $318

Branded share of claims

47.1%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 21 $15,755
Eliquis Apixaban Brand 12 $6,829
Spironolactone Generic 23 $121
Carvedilol Generic 14 $81

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$283,119

Medicare's payments for the services billed

Medicare patients

384

Average age 76

Services billed

923

174 women, 210 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 62%
Arthritis 53%
Atrial fibrillation 51%
Diabetes 50%
Chronic kidney disease 46%
COPD 39%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

262 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record